Compare MPC & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPC | SYK |
|---|---|---|
| Founded | 1887 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.3B | 125.7B |
| IPO Year | 2011 | 1994 |
| Metric | MPC | SYK |
|---|---|---|
| Price | $360.00 | $330.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | $229.75 | ★ $415.57 |
| AVG Volume (30 Days) | ★ 2.3M | 2.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.65% | 1.12% |
| EPS Growth | ★ 31.15 | 8.25 |
| EPS | ★ 19.30 | 5.23 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $6.61 | $9.80 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | ★ $18.78 | $62.68 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $161.93 | $281.00 |
| 52 Week High | $367.60 | $396.86 |
| Indicator | MPC | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 70.94 | 44.71 |
| Support Level | $237.93 | $318.47 |
| Resistance Level | N/A | $335.45 |
| Average True Range (ATR) | 10.81 | 8.40 |
| MACD | 1.13 | -2.46 |
| Stochastic Oscillator | 91.76 | 4.35 |
Marathon Petroleum is a leading integrated downstream and midstream energy company that operates 13 refineries in the Gulf Coast, Mid-Continent, and West Coast regions of the United States with an aggregate crude oil refining capacity of 3.0 million barrels per day. The company is one of the largest producers of renewable diesel in the US; its Dickinson, North Dakota facility has the capacity to produce 184 million gallons per year, and its Martinez, California, joint venture facility (a 50/50 partnership with Neste) reached its full capacity of 730 million gallons per year in late 2024. Marathon also owns the general partner and approximately 64% of MPLX LP, a large-cap master limited partnership that owns and operates midstream energy infrastructure and logistics assets.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.